Removing Incentives To Lower Drug Prices Isn’t Pharma ‘Reform’
Tuesday, January 14th 2025, 12:37:28 pm
article
Delinking legislation is a giveaway to the pharmaceutical industry that will prove costly to taxpayers and Part D enrollees.
Breaking
FBI Director Kash Patel made good on his threat to sue The Atlantic. Patel filed a lawsuit Monday seeking $250 million,...
State health officials are sounding the alarm about a new designer drug that's been unleashed on the world courtesy of everyone's favorite communists: China....
Academics and lawmakers say repeated tariff reversals and announcements are blurring political and market lines....
